Jun 08, 2021 / 01:40PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Welcome, everybody, to the Goldman Sachs 42nd Annual Healthcare Conference. I'm pleased to have Avantor joining us today at our conference. We have President and CEO, Michael Stubblefield; Executive Vice President and CFO, Thomas Szlosek; and Tommy Thomas, Vice President of Investor Relations. Welcome, everybody. Thank you very much for joining us.
Michael Stubblefield - Avantor, Inc. - President, CEO & Director
Thanks, Matt. Happy to be here. Appreciate you hosting us.
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Great. Maybe if we'll start out, I'll let you guys set the stage a little bit. It's been a few years since the IPO. I think at the time, you're telling the story of resetting the organic growth rate higher, strengthen the balance sheet, which I believe you've largely achieved at this point, and it's been impressive. So maybe kind of give us a mark-to-market on Avantor today
Avantor Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot